chrX-75784065-C-T

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_138703.5(MAGEE2):​c.987G>A​(p.Met329Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0021 in 1,208,479 control chromosomes in the GnomAD database, including 2 homozygotes. There are 796 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0011 ( 0 hom., 25 hem., cov: 22)
Exomes 𝑓: 0.0022 ( 2 hom. 771 hem. )

Consequence

MAGEE2
NM_138703.5 missense

Scores

1
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.521
Variant links:
Genes affected
MAGEE2 (HGNC:24935): (MAGE family member E2) This gene encodes a member of the E subfamily of MAGE (melanoma antigen-encoding gene) gene family. The gene is intronless and the encoded protein has two of the MAGE domains which are characteristic of MAGE family proteins. [provided by RefSeq, Sep 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009828895).
BS2
High Hemizygotes in GnomAd4 at 25 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
MAGEE2NM_138703.5 linkuse as main transcriptc.987G>A p.Met329Ile missense_variant 1/1 ENST00000373359.4
LOC107985664XR_007068273.1 linkuse as main transcriptn.822-7227C>T intron_variant, non_coding_transcript_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
MAGEE2ENST00000373359.4 linkuse as main transcriptc.987G>A p.Met329Ile missense_variant 1/1 NM_138703.5 P1

Frequencies

GnomAD3 genomes
AF:
0.00113
AC:
127
AN:
112332
Hom.:
0
Cov.:
22
AF XY:
0.000725
AC XY:
25
AN XY:
34484
show subpopulations
Gnomad AFR
AF:
0.000453
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000281
Gnomad ASJ
AF:
0.00264
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00190
Gnomad OTH
AF:
0.00132
GnomAD3 exomes
AF:
0.000993
AC:
180
AN:
181329
Hom.:
0
AF XY:
0.000889
AC XY:
59
AN XY:
66371
show subpopulations
Gnomad AFR exome
AF:
0.000380
Gnomad AMR exome
AF:
0.0000729
Gnomad ASJ exome
AF:
0.00201
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000315
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00181
Gnomad OTH exome
AF:
0.000887
GnomAD4 exome
AF:
0.00219
AC:
2405
AN:
1096092
Hom.:
2
Cov.:
31
AF XY:
0.00213
AC XY:
771
AN XY:
362310
show subpopulations
Gnomad4 AFR exome
AF:
0.000606
Gnomad4 AMR exome
AF:
0.0000852
Gnomad4 ASJ exome
AF:
0.00201
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000351
Gnomad4 FIN exome
AF:
0.0000260
Gnomad4 NFE exome
AF:
0.00265
Gnomad4 OTH exome
AF:
0.00195
GnomAD4 genome
AF:
0.00113
AC:
127
AN:
112387
Hom.:
0
Cov.:
22
AF XY:
0.000724
AC XY:
25
AN XY:
34549
show subpopulations
Gnomad4 AFR
AF:
0.000452
Gnomad4 AMR
AF:
0.000281
Gnomad4 ASJ
AF:
0.00264
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00190
Gnomad4 OTH
AF:
0.00130
Alfa
AF:
0.00216
Hom.:
91
Bravo
AF:
0.00120
TwinsUK
AF:
0.00270
AC:
10
ALSPAC
AF:
0.00277
AC:
8
ESP6500AA
AF:
0.000261
AC:
1
ESP6500EA
AF:
0.00149
AC:
10
ExAC
AF:
0.000923
AC:
112
EpiCase
AF:
0.00142
EpiControl
AF:
0.00160

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMay 11, 2022The c.987G>A (p.M329I) alteration is located in exon 1 (coding exon 1) of the MAGEE2 gene. This alteration results from a G to A substitution at nucleotide position 987, causing the methionine (M) at amino acid position 329 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.32
BayesDel_addAF
Benign
-0.81
T
BayesDel_noAF
Benign
-0.94
CADD
Benign
11
DANN
Benign
0.89
DEOGEN2
Benign
0.0092
T
FATHMM_MKL
Benign
0.070
N
LIST_S2
Benign
0.46
T
M_CAP
Benign
0.0016
T
MetaRNN
Benign
0.0098
T
MetaSVM
Benign
-0.93
T
MutationAssessor
Benign
0.55
N
MutationTaster
Benign
1.0
N
PrimateAI
Uncertain
0.74
T
PROVEAN
Benign
-1.0
N
REVEL
Benign
0.059
Sift
Benign
0.065
T
Sift4G
Benign
0.099
T
Polyphen
0.0020
B
Vest4
0.067
MutPred
0.62
Gain of catalytic residue at M329 (P = 0.0102);
MVP
0.50
MPC
0.012
ClinPred
0.0061
T
GERP RS
0.86
Varity_R
0.21
gMVP
0.17

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs146639449; hg19: chrX-75003900; API